IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Kynam Capital Management, LP

Q2 2026 Holdings

Filed 2026-08-14 | 32 holdings | $1.8B | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Celldex Therapeutics Inc New(CLDX)COM NEW15117B202$198.1M5,322,90810.9%
Syndax Pharmaceuticals Inc(SNDX)COM87164F105$176.0M8,050,9599.7%
Vaxcyte Inc(PCVX)COM92243G108$169.9M2,922,3359.4%
Cogent Biosciences Inc(COGT)COM19240Q201$141.9M3,667,0977.8%
Vera Therapeutics Inc(VERA)CL A92337R101$124.0M2,890,0596.9%
Viridian Therapeutics Inc(VRDN)COM92790C104$118.6M6,453,8776.6%
Travere Therapeutics Inc(TVTX)COM89422G107$113.6M2,000,0006.3%
Beam Therapeutics Inc(BEAM)COM07373V105$97.5M2,840,7925.4%
Urogen Pharma LTD(URGN)COMM96088105$89.6M2,434,2075.0%
Legend Biotech Corp(LEGN)SPONSORED ADS52490G102$86.7M3,001,2054.8%
Cytomx Therapeutics Inc.(CTMX)COM23284F105$81.4M21,703,0934.5%
Relay Therapeutics Inc(RLAY)COM75943R102$61.7M3,300,0003.4%
Cullinan Therapeutics Inc(CGEM)COM230031106$56.7M3,114,1323.1%
MBX Biosciences Inc(MBX)COM55287L101$51.6M934,7992.9%
Immunocore Hldgs PLC(IMCR)ADS45258D105$43.7M1,375,0002.4%
Nurix Therapeutics Inc(NRIX)COM67080M103$29.0M1,194,7571.6%
Sutro Biopharma Inc(STRO)COM SHS869367201$29.0M872,5581.6%
Biocryst Pharmaceuticals Inc(BCRX)COM09058V103$25.2M2,522,6601.4%
Pharvaris N V(PHVS)COMN69605108$22.9M661,7951.3%
Summit Therapeutics Inc(SMMT)COM86627T108$17.5M1,200,0001.0%
Prelude Therapeutics Inc(PRLD)COM74065P101$12.9M2,415,0870.7%
Insmed Inc(INSM)COM PAR $.01457669307$10.7M100,0000.6%
Burning Rock Biotech LTD(BNR)SPONSORED ADS12233L206$10.5M1,238,5630.6%
Geron Corp(GERN)COM374163103$8.8M6,836,3180.5%
Amarin Corp PLC(EH3)SPONSORED ADR023111404$8.5M532,9820.5%
Alector Inc(ALEC)COM014442107$7.7M3,808,4940.4%
Parabilis Medicines Inc(PBLS)COM698955101$6.8M250,0000.4%
Caribou Biosciences Inc(CRBU)COM142038108$4.4M2,503,3020.2%
Proqr Thrapeutics N VSHS EURON71542109$2.9M1,566,3170.2%
Candel Therapeutics Inc(CADL)COM137404109$996.4K96,7410.1%
Engene Therapeutics Inc(ENGN)COM29286X101$792.1K457,8550.0%
Traws Pharma Inc(TRAW)COM NEW68232V884$71.2K84,4000.0%